Enteric Disease Testing Market Is Likely to Experience a Tremendous Growth by 2029
Additionally, according to, the CDC around 11 to 20 million cases of typhoid fever and 2,00,000 mortalities occur across the globe each year around 350 patients are diagnosed with typhoid fever, and 90% of people are diagnosed with paratyphoid fever every year. Each year around 1.4 to 4 million cases of cholera are detected and around 21,000 to 143,000 mortalities are recorded across the globe. This rising number of enteric disease cases is resulting in increasing demand for enteric disease testing. Asia-Pacific is also expected to witness significant growth in the market. The rising prevalence of cholera and rising awareness regarding such disorders is primarily contributing to the market growth in the region. The three largest cholera endemic countries across the globe include India, China, and Indonesia. This, in turn, is driving the demand for enteric disease testing in the region.
To Request a Sample of our Report on Enteric Disease Testing Market: https://www.omrglobal.com/request-sample/enteric-disease-testing-market
• The market number available for - 2023-2029
• Base year- 2022
• Forecast period- 2023-2029
· By Pathogen Tested
· By Technology
· By End-User
· North America
· Rest of the World
· Competitive Landscape- Bio-Rad Laboratories, Inc., Abbott Laboratories, Quest Diagnostics, BioMerieux SA, and Meridian Bioscience, Inc.
Enteric Disease Testing Market Report by Segment
By Pathogen Tested
· Polymerase Chain Reaction (PCR)
· Chromatography & spectrometry
A full Report of Enteric Disease Testing Market is Available @ https://www.omrglobal.com/industry-reports/enteric-disease-testing-market
Enteric Disease Testing Market Report by Region
· United States
· Rest of Europe
· South Korea
· Rest of APAC
Rest of the World
• Latin America
• Middle East and Africa
· AsureQuality Ltd.
· Becton, Dickinson and Company (BD)
· Bio-Rad Laboratories, Inc.
· Certified Laboratories Inc.
· Coris BioConcept SPRL
· Eurofins Scientific
· Hardy Diagnostics
· Intertek Group plc
· Merck Group (Merck KGaA)
· Mérieux NutriSciences Corp
· Neogen Corp
· Nova Biologicals
· PerkinElmer, Inc.
· Quest Diagnostics
· Romer Labs Division Holding GmbH
· SGS SA
· Symbio Laboratories
· TÜV SÜD
Reasons to buy from us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/enteric-disease-testing-market
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Enteric Disease Testing Market Is Likely to Experience a Tremendous Growth by 2029 here
News-ID: 2937654 • Views: 180
More Releases from Orion Market Research
US Consumer Packaging Market Booming Worldwide with Latest Trend and Future Scop …
The US consumer packaging market is estimated to grow at a CAGR of 4.5% during the forecast period. Rising demand for flexible packaging across end-user industries is primarily leveraging market growth. As per the Flexible Packaging Association (FPA), in the US, the flexible packaging industry generated $31.8 billion in sales in 2018. It is the second-largest packaging segment in the country accounted for nearly 19% of the $170 billion US
North American Consumer Packaging Market Will Generate Record Revenue by 2029
North American consumer packaging market is estimated to grow at a CAGR of 3.8% during the forecast period. North American is the leader in the pharmaceutical industry, coupled with the presence of several large and small pharmaceutical firms in the region. The region is renowned for conducting massive R&D and produce bulk pharmaceuticals. As per the European Federation of Pharmaceutical Industries and Associations (EFPIA), in 2017, North American held 48.1%
European Consumer Packaging Market Comprehensive Insight by Growth Rate, Industr …
The European consumer packaging market is estimated to grow at a CAGR of 4.8% during the forecast period. Significant rise in the packaging industry and increasing pharmaceutical production are some key factors primarily contributing to market growth. As per the PlasticsEurope, in 2018, the European plastics industry generated revenue of over $413.3 billion, with a positive trade balance of over $17.2 billion. In 2018, 9.4 million tons of plastic post-consumer
Asia-Pacific Consumer Packaging Market is Anticipated to Increase at a Stable CA …
Asia-Pacific consumer packaging market is estimated to grow at a significant CAGR of 7.0% during the forecast period. The major factors contributing to the growth of the market include a significant rise in the production of food and beverage and pharmaceuticals in the region. The rising demand for processed food is one of the major causes that accelerates the demand for packaging solutions in the region. As per the India
More Releases for Disease
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Gaucher Disease Treatment Market, by Disease Type, Therapy Type
Gaucher disease is an autosomal recessive inherited metabolism disorder where a type of fat (lipid) called glucocerebroside is unable to degrade. Body synthesis enzyme called glucocerebrosidase, which breakdowns and reprocesses glucocerebroside. Gaucher disease is caused by mutations of a single gene called GBA, which leads to very low levels of glucocerebrosidase enzyme leading to low degradation of glucocerebroside. There are three types of Gaucher disease namely: type 1, type 2,
Autoimmune Disease Diagnostic Market By Disease, Tests Type, Regions, Companies
"The Latest Research Report Autoimmune Disease Diagnostic Market, Global Forecast, By Disease, Tests Type, Regions, Companies provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Autoimmune Disease Diagnostic Market is anticipated to exceed US$ 18 Billion, experiencing a significant growth over the forecast period. Autoimmune diseases take place when there is disruption of the usual control process (immune system of the body becomes
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and